Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of the effectiveness of methocarbamol in the treatment of spasticity after spinal cord injury
2022-000788-30Phase 4Terminated
- Sponsor
- Uzdrowisko Kamień Pomorski
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of methocarbamol in Muscle spasm, spinal cord injury (SCI) and spasticity, sponsored by Uzdrowisko Kamień Pomorski. Primary endpoint: Surface EMG activity of hip flexors and knee extensors. Started Sep 2022; status: terminated.
02
Drugs
methocarbamol
03
Conditions
Muscle spasmspinal cord injury (SCI)spasticity
Beyond the preview
Go deeper on 2022-000788-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-000788-30.